>R&D >R&D Pipeline
Takeda discloses ethical drugs under development that have entered phase 1 clinical trials or above in Japan, the U.S. or Europe. The pipeline is updated each quarter.
|PDF 1.4MB 15P|
Clinical trials are conducted on humans for drugs for which basic research and non-clinical trials have been completed. Drugs that have undergone efficacy and safety evaluation via three phases of clinical trials are launched onto the market after approval by the regulatory authorities.